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A number of symptomatic patients with coro-
nary artery disease undergo revascularization 
without definite evidence that particular coronary 
stenosis is responsible for their symptoms [1]. 
Currently, the borderline coronary artery stenoses 
are most commonly assessed by intravascular 
ultrasound and fractional flow reserve (FFR) along-
side with quantitative coronary angiography [2]. 
FFR measurement, as performed by pressure wire 
(PW), requires its multiple removals during FFR 
and percutaneous coronary intervention (PCI), and 
results in a relatively high signal drift with loss of 
accuracy. The novel exchange microcatheter (RXi) 
was invented to assess FFR in a safer mode [3, 4].
A 61-year-old man was admitted to hospital 
with exertional stenocardia. The patient under-
went myocardial infarction in 1988 and coronary 
artery bypass grafting operation in 1999. Angiog-
raphy revealed total occlusion of the left anterior 
descending artery (LAD), as previously. In the 
right coronary artery (RCA) occurred dissemi-
nated, multi-segmental stenoses up to 40% with 
borderline stenosis of 60% in the distal portion 
(Fig. 1A). The aorto-marginal saphenous vein 
Figure 1. Fluoroscopic images of the right coronary artery (RCA); A. Cine image of stenosed RCA; B. Cine image of 
RCA and the Acist Navvus microcatheter during the measurement, and its distal part with the radiopaque marker (labe- 
led with white arrow); C. Cine image of RCA after angioplasty with stent deployment (marked with white arrow); D. Frac-
tional flow reserve (FFR) of distal part of RCA before stent implantation. E: FFR of distal part of RCA after stent implantation; 
Pa — pressure proximal to the lesion; Pd — pressure distal to the lesion; Pv — coronary venous pressure.
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graft (SVG Ao-Mg) graft was occluded. The Acist 
Navvus microcatheter (ACIST Medical Systems, 
Eden Prairie, MN, USA) was used to perform 
FFR measurements in RCA. Two intracoronary 
boluses of adenosine were administered dur-
ing the procedure: 200 µg and 400 µg. The final 
result was as follows: 0.74 confirmed the signifi-
cance of RCA stenosis (Fig. 1D). Simultaneously, 
PCI of the distal RCA segment was performed. 
After predilatation with non-compliant balloon 
catheter 2.5 × 15 mm 16 atm, DES CID Cre8 
(Carbostent&Implantable Devices, Saluggia, Italy) 
3.0 × 20 mm 16 atm was deployed (Fig. 1B, C). 
Control FFR after intracoronary administration of 
400 µg of adenosine was 0.85, which confirmed that 
culprit lesion was treated (Fig. 1E).
The FFR is recommended for the assessment 
of borderline coronary lesions (stenoses between 
40% and 70%) by international European cardiol-
ogy societies [5]. It has been shown that FFR-
-guided PCI results in significantly lower rates of 
death and myocardial infarctions than PCI, based 
on angiographic assessment alone in 4-year follow-
up [6]. The FFR-guided PCI coexisting with the 
optimal medical therapy is the most favorable ap-
proach in patients with stable angina, remarkably 
reducing the need of urgent revascularizations [7]. 
In individuals with disseminated, multi-segmental 
and borderline stenoses, the pull-back method with 
continuous recording of coronary artery pressure is 
used for FFR measurement. The gold standard is 
continuous intravenous adenosine infusion, where-
as intracoronary infusion of adenosine bolus is 
a shorter modification that brings the similar propor-
tion of stenosis when high doses of adenosine bo-
luses are administered [8]. It was revealed that high 
boluses of intracoronary adenosine up to 600 µg 
are safe for the patient [8]. Devices intended to be 
applied for FFR measurement are underutilized 
due to inconvenient usage. It could be caused by 
difficulties in PW delivery in tortuous and narrowed 
arteries and susceptibility to kinking [3]. Further-
more, PCI requires withdrawal of the PW and may 
cause complications due to this maneuver. The RXi™ 
system is a new FFR technology, where ultrathin 
monorail microcatheter is a key part of the device. 
The RXi microcatheter could be used with differ-
ent guide-wires (GWs), which are appropriate for 
the particular artery anatomy and morphology [3]. 
It is noteworthy, that the RXi microcatheter is 
compatible with standard 0.014” GWs. The Mi-
crocatheter Navvus is elliptically-shaped. The 
0.020” × 0.025” dimensions are comparable to 
the diameter of 0.022” circular-shaped wire. The 
fiber optic sensor is attached 5 mm from the 
distal tip and the radiopaque marker 2.5 mm 
from the distal tip [4]. The RXi microcatheter has 
a significant advantage in creating the possibility to 
obtain measurements without loss of wire access to 
the artery [4]. The FFR measured after coronary 
stenting is a clinically important tool to evaluate 
the results of the coronary intervention. However, 
the measurement of FFR after stent implantation 
requires re-crossing the stent with PW which entails 
a significant risk of its incorrect position or, in the 
case of stenting by PW itself re-connecting the FFR 
system, increases the likelihood of signal drift. RXi 
microcatheters allow the FFR measurement after 
revascularization using the same wire which was used 
during stent implantation, eliminating the need to re-
cross the coronary artery or to disconnect the FFR 
system. Moreover, if it is necessary to re-place the 
RXi microcatheter in the vessel, there is no need for 
re-calibration [4]. Some doubts may arise  if the larger 
diameter affects FFR value. A recently published 
study from New Zealand showed no influence of the 
Navvus Microcatheter’s dimensions on the results 
obtained by FFR. In addition, a good correlation be-
tween the results obtained with the new method and 
a standard PW was noticed [3]. However, the larger 
diameter of the catheter may cause some difficul-
ties with passing to the peripheral part of narrowed, 
calcified and tortuous arteries as compared to PWs 
alone, which may in some cases limit the use of RXi 
microcatheter.
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